|

NKT3964 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • NiKang Therapeutics, Inc.1

Indications

  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast1
  • CCNE1 Amplification1
  • Endometrial Diseases1
  • Progesterone Receptor-positive Breast Cancer1
  • Metastatic Ovarian Carcinoma1

Little Rock, Arkansas1 trial

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

University of Arkansas Medical School

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.